NRAS and melanoma: MAPK signaling inhibitor MEK162 abolished the oncogenic roles of FUT8-AS1 silencing in melanoma, which further supports that miR-145-5p/NRAS/MAPK signaling is the critical mediator of the roles of FUT8-AS1 in melanoma.